Shares of pharmacy benefit managers extended losses Tuesday after Pfizer Inc. Chief Executive Officer Albert Bourla said ...

So when vaccine skeptic Robert F. Kennedy Jr. was offered the top job at the Department of Health and Human Services, Pfizer ...

The push to replace Albert Bourla as Pfizer’s CEO drew attention from the pharma industry but was soon derailed by several ...

President-elect was happy that "he and his program [Operation Warp Speed] contributed significantly," to vaccine development, ...

Pfizer said Tuesday it does not expect the Trump administration to make major changes to vaccine policy next year even with ...

Pfizer is fending off investors’ fears about threats to its vaccine business under the Trump administration.

Shares of Pharmacy-benefit managers (PBMs) including CVS Health Corp (NYSE:CVS), UnitedHealth Group Inc (NYSE:UNH) and Cigna ...

The Vyndaqel family of drugs for the treatment of transthyretin amyloid cardiomyopathy is Pfizer’s fourth top-selling product ...

Revenue in 2025 will be $61 billion to $64 billion, Pfizer said, in line with predictions by Wall Street analysts.

Shares of pharmacy benefit managers extended losses Tuesday after Pfizer CEO Albert Bourla said President-elect Donald Trump ...

Shares of UnitedHealth (NYSE:UNH) and CVS Health (NYSE:CVS) continued to trade lower on Tuesday after Pfizer (NYSE:PFE) CEO ...

Pfizer is in a strong position to continue making a positive impact for patients and delivering on our financial commitments in 2025. Our team will build on a year of disciplined execution in 2024 and ...